Welcome to MSM Protein Technologies
MSM Protein Technologies is an early drug development company with proven expertise in antibody drug discovery against integral membrane proteins. Our pipeline includes a number of first-in-class pre-clinical stage antibodies targeting several GPCRs. The company is a pioneer at the forefront of generating human antibodies against complex membrane proteins. MSM Protein Technologies has a solid record of successful partnerships with a number of Big Pharma companies in drug discovery and development programs.
Our pipeline is mainly focused on immunologic and oncologic diseases including:
- Blood cancers and solid tumors such as acute T-cell lymphoblastic leukemia (T-ALL), refractory diffuse large B-cell lymphoma (DLBCL), melanoma, glioma, pancreatic cancer and gastric cancer.
- Graft-versus-host disease (GVHD).
- Autoimmune diseases associated with Th17 cells like multiple sclerosis (MS), psoriasis, rheumatoid arthritis.
- Respiratory diseases such as idiopathic pulmonary fibrosis (IPF), human respiratory syncytial virus (RSV), chronic obstructive pulmonary disease (COPD) and asthma.
If you believe your organization and MSM Protein Technologies may have synergy, we want to hear from you! Please visit our Contact & Jobs page for more information.